Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Universitat d'Alacant
Alicante, EspañaPublicacións en colaboración con investigadores/as de Universitat d'Alacant (17)
2023
-
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)
British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871
2022
-
Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation
Molecular Therapy - Nucleic Acids, Vol. 27, pp. 838-853
2020
-
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort
Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148
-
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)
Lung Cancer, Vol. 150, pp. 62-69
-
Spanish guidelines for diagnosis, management, treatment, and prevention of dress syndrome
Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 4, pp. 229-253
2019
-
DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: A retrospective study
Journal of Biomedical Science, Vol. 26, Núm. 1
2017
-
Timed Up and Go Test Performance as an Indicator of Fall History in Institutionalized Elderly
Topics in Geriatric Rehabilitation, Vol. 33, Núm. 4, pp. 273-279
2016
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: Results from the GEICAM/2003-10 study
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3788-3795
2014
-
Importance of exercise in the control of metabolic and inflammatory parameters at the moment of onset in type 1 diabetic subjects
Experimental and Clinical Endocrinology and Diabetes, Vol. 122, Núm. 6, pp. 334-340
-
Response to circulatory death determination in uncontrolled organ donors: A panel viewpoint
Annals of Emergency Medicine
2012
-
Natural products from antarctic colonial ascidians of the genera Aplidium and Synoicum: Variability and defensive role
Marine Drugs, Vol. 10, Núm. 8, pp. 1741-1764
2011
-
Reliability of 4-m and 6-m walking speed tests in elderly people with cognitive impairment
Archives of Gerontology and Geriatrics, Vol. 52, Núm. 2
2010
-
Chemical defenses of tunicates of the genus Aplidium from the Weddell Sea (Antarctica)
Polar Biology, Vol. 33, Núm. 10, pp. 1319-1329
2007
2006
-
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): Impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen
Annals of Oncology, Vol. 17, Núm. 8, pp. 1205-1212